ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,959Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1456

$1.64M Total Retail Price of All Prescriptions

Rank: 23 out of 1456

572 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 572 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 572 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 17,606 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 1,269 850 1 1
FUROSEMIDE 692 503 2 7
LISINOPRIL 666 359 3 3
SIMVASTATIN 606 455 4 2
HYDROCODONE-ACETAMINOPHEN 594 406 S3 5 6
METFORMIN HCL 589 358 6 8
OMEPRAZOLE 538 387 7 5
METOPROLOL TARTRATE 535 380 8 12
CRESTOR 529 378 9 26
LEVOTHYROXINE SODIUM 528 422 10 4
PRAVASTATIN SODIUM 488 344 11 9
GLIPIZIDE ER 365 200 12 86
NEXIUM 364 227 13 23
SERTRALINE HCL 360 264 14 25
HYDROCHLOROTHIAZIDE 354 189 15 10
CITALOPRAM HBR 352 258 16 22
GABAPENTIN 339 202 17 13
CARVEDILOL 322 210 18 20
ZOLPIDEM TARTRATE 316 178 19 14
METOPROLOL SUCCINATE 285 180 20 19
POTASSIUM CHLORIDE 277 214 21 15
RANITIDINE HCL 275 182 22 27
NAMENDA 263 224 23 38
RISPERIDONE 259 167 24 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 247 162 25 24
MELOXICAM 242 188 26 30
FAMOTIDINE 236 122 27 45
CYCLOBENZAPRINE HCL 230 113 R 28 66
WARFARIN SODIUM 225 177 29 21
TRAMADOL HCL 220 125 30 17
CLONIDINE HCL 216 129 31 39
DIOVAN 215 166 32 35
JANUVIA 205 137 33 68
DONEPEZIL HCL 198 180 34 29
NAPROXEN 198 116 34 100
DIOVAN HCT 198 121 34 59
QUETIAPINE FUMARATE 197 144 37 78
ATORVASTATIN CALCIUM 189 126 38 11
EXELON 188 149 39 105
CLOPIDOGREL 177 125 40 32
COMBIVENT 174 102 41 110
LEVETIRACETAM 165 137 42 97
RAMIPRIL 162 136 43 98
SINGULAIR 158 108 44 83
LOSARTAN POTASSIUM 157 119 45 16
LEVOFLOXACIN 153 98 46 79
TRAZODONE HCL 151 87 47 47
ALLOPURINOL 150 98 48 31
ATENOLOL 149 130 49 18
MIRTAZAPINE 147 117 50 65
DIVALPROEX SODIUM 145 91 51 108
HYDRALAZINE HCL 140 93 52 48
ESCITALOPRAM OXALATE 136 77 53 74
PLAVIX 132 102 54 46
ISOSORBIDE MONONITRATE ER 131 97 55 60
COLCRYS 130 94 56 122
MONTELUKAST SODIUM 127 75 57 135
VESICARE 127 92 57 200
AMLODIPINE BESYLATE-BENAZEPRIL 125 106 59 61
PHENYTOIN SODIUM EXTENDED 123 89 60 128
LEVEMIR 117 90 61 161
AMOX TR-POTASSIUM CLAVULANATE 107 62 62 118
BENZTROPINE MESYLATE 106 51 R 63 222
OLANZAPINE 105 73 64 183
SEROQUEL 105 70 64 154
ADVAIR DISKUS 104 75 66 63
BYSTOLIC 103 79 67 102
INSULIN SYRINGE 100 70 68 64
AZITHROMYCIN 100 59 68 44
SPIRIVA 99 68 70 75
THEOPHYLLINE ANHYDROUS 96 95 71 238
DIGOXIN 95 72 72 62
TAMSULOSIN HCL 94 87 73 34
FLUTICASONE PROPIONATE 92 62 74 28
PANTOPRAZOLE SODIUM 87 63 75 43
EXFORGE 87 73 75 211
KLOR-CON M20 83 41 77 51
PREDNISONE 83 50 77 42
NOVOLOG 82 70 79 104
AMITRIPTYLINE HCL 82 37 R 79 70
DICLOFENAC SODIUM 82 51 79 95
METOCLOPRAMIDE HCL 82 48 79 125
GLIPIZIDE XL 81 67 83 134
VALPROIC ACID 81 42 83 230
BENICAR 80 36 85 130
TRILIPIX 79 45 86 188
ALENDRONATE SODIUM 78 56 87 36
PROAIR HFA 77 39 88 69
HYDROXYZINE HCL 76 51 R 89 164
NIASPAN 75 52 90 127
CIPROFLOXACIN HCL 73 39 91 58
METOLAZONE 72 46 92 210
NOVOLOG MIX 70-30 72 43 92 204
VENLAFAXINE HCL ER 72 43 92 89
HALOPERIDOL 68 33 95 254
NIFEDIPINE ER 68 59 95 81
NOVOLIN 70-30 66 56 97 144
BISOPROLOL-HYDROCHLOROTHIAZIDE 66 60 97 93
ROPINIROLE HCL 66 65 97 90
LOSARTAN-HYDROCHLOROTHIAZIDE 61 43 100 41
GLIPIZIDE 61 34 100 53
AZOR 61 33 100 262
NASONEX 59 38 103 246
MECLIZINE HCL 59 59 103 101
EXFORGE HCT 59 43 103 286
LANSOPRAZOLE 58 56 106 137
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 29 107 107
FLUOXETINE HCL 55 29 107 55
TOPIRAMATE 53 0 109 196
MEGACE ES 53 43 R 109 483
NITROGLYCERIN PATCH 53 53 109 178
FLUPHENAZINE HCL 51 44 112 495
FENOFIBRATE 50 14 113 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.